# Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

> **NCT00513214** · PHASE1,PHASE2 · COMPLETED · sponsor: **XOMA (US) LLC** · enrollment: 68 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** XOMA 052
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00513214
- **Lead sponsor:** XOMA (US) LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-06
- **Final completion:** 2010-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2011-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00513214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00513214, "Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00513214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*